-
Notifications
You must be signed in to change notification settings - Fork 1
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
OSA Series 2 Meeting Nov 19th (No meeting Nov 12th) #102
Comments
Food for thought re: NEU ADME assays. I thought it might be useful to look at potential candidates in the context of their matched pairs, hopefully this is helpful. Compounds in dotted boxes are ones that we should have stock of at UCL (to be confirmed) and that we don't have any ADME data on yet. Note that we have ADME data for some additional compounds, but I've based this selection on what's included in the current SAR tables. There are also a few compounds from NEU for which we don't have ADME - for these I've asked @loriferrins if she has this data and can share. I have not included any compounds from @danielgedder or ones that were donated from DNDi as potential candidates because we don’t have solid stock of them at UCL. However we could consider trying to source more of those if we think it’s important to get ADME data on them. For me, the four top priority compounds are: Other compounds potentially of interest: At this point, my opinion is that it’s not really worth sending anything for ADME with MRSA MIC >4. Happy to have this up for discussion though as we do have room to include some of these with the priority ones. |
@danaklug this is a really helpful summary, as always! I completely agree with your analysis - you could include 875 if you wanted to (purely based on potency), though I don't anticipate it will be any better/different than 876. I also agree that there isn't a lot of value in getting data on compounds that are >4ug/mL. I have also emailed the missing ADME data to Dana as this came in earlier in the week. |
Thanks Lori, new data has been added to the master sheet and uploaded. |
Cluster analysis of the Series 2 compounds
|
So, confirming choices Actions Nice to see you on camera @MFernflower - first time I think! |
Closing: data incorporated into wiki: https://github.com/opensourceantibiotics/Series-2-Diarylimidazoles/wiki/Metabolic-Clearance-Data |
This page is draft until this text is removed.
Meeting Nov 5th 2021 at 2pm UK time at https://ucl.zoom.us/j/92800004715. Follows on from #100
Recording:
On the call:
PREVIOUS ACTIONS
The text was updated successfully, but these errors were encountered: